|
|
|||||||||
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Availability of National HIV Serosurveillance Summary -- Results through 1992CDC collaborates with state and local health departments, other federal agencies, blood-collection agencies, hospitals, and medical research institutions to conduct human immunodeficiency virus (HIV) seroprevalence surveys and studies in selected populations. These activities constitute a serosurveillance network to monitor the prevalence of HIV infection in the United States. These surveys monitor various populations, including persons at increased risk (e.g., persons attending drug-treatment centers and sexually transmitted disease clinics) and broader populations (e.g., applicants for military service and childbearing women) (Figure_1). Single copies of National HIV Serosurveillance Summary -- Results through 1992 (1) are available free from the CDC National AIDS Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003; telephone (800) 458-5231. Reference
Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|